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CHAPTER 1 INTRODUCTION 
1.1 p120 Catenin 
p120 Catenin (p120ctn) is the prototypic member of a subfamily of armadillo-repeat 
domain (Arm domain) proteins involved in intercellular adhesion. p120ctn was originally 
identified as a substrate of Src oncoprotein [1]. cDNA cloning revealed that it contains an Arm 
domain which shares 22% identity with that of β-catenin [2, 3]. Further experiments demonstrated 
its direct interaction with multiple types of the cadherins, including E-cadherin, V-cadherin, P-
cadherin and VE-cadherin [4-7]. Cadherin function is modulated by a group of catenins, including 
α-catenin, β-catenin, -catenin (plakoglobin) and p120ctn, which interact with the cadherin 
intracellular domain in direct or indirect manner [8]. β-Catenin binds to the catenin-binding 
domain (CBD) of cadherins and functionally links cadherins with the actin cytoskeleton through 
α-catenin [9-11], while p120ctn is responsible for stabilizing cadherin-catenin complexes at the 
cell surface by interacting with the juxtamembrane domain (JMD) of cadherins (Figure 1.1) [12-
14]. Through the interaction with cadherin JMD, p120ctn is implicated in various processes, 
including supporting lateral clustering of cadherin molecules and adhesive strength [15], as well 
as suppression of cell motility [16]. Besides its function in maintenance of the epithelial barrier, 
p120ctn also plays important roles in regulation of intracellular signal transduction and gene 
transcription [17]. 
1.1.1 Isoforms of p120 catenin 
Most cell types are observed expressing multiple p120ctn isoforms which are derived from 
alternative splicing of a single gene [4, 18]. The human p120ctn gene (CTNND1), located on 
chromosome 11q12.1,  is consist of 21 exons which potentially encode up to 32 protein isoforms 
due to alternative splicing. At N-terminus, the use of four different ATGs as the translational start 
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site results in the expression of p120ctn isoform 1, 2, 3 or 4 [18]. Furthermore, alternative splicing 
of the C-terminal end leads to use of exon A (exon 18) and/or exon B (exon 20), or neither of them. 
On rare occasions, p120ctn contains a sequence encoded by exon C (exon 11), which is inserted 
within Arm domain. Therefore, the longest isoform of human p120ctn is 1ABC which comprises 
968 amino acid residues (Figure 1.2) [19]. Various combinations of these N- and C-terminal exons 
could generate multiple p120ctn isoforms observed as diverse bands on SDS-PAGE. The tissue 
type-specific expression of p120ctn isoforms was obvious, and the presence of isoforms varies in 
abundance among different cell types [18]. These cell type-associated expression patterns of 
p120ctn isoforms implies that various isoforms of p120ctn might have distinct or preferential 
functions [20, 21]. The functional consequence of the multitude of p120ctn variants has not been 
very clear. The alternative splicing usually affects only the N- and C-terminal domains, so the Arm 
domain is intact and free to bind to cadherins. The mesenchymal and motile cells, such as 
macrophages and fibroblasts, preferentially express p120ctn isoform 1A, whereas the sessile cells, 
such as epithelial cells, predominantly express short isoforms, such as p120ctn 3A. Non-adherent 
cells, including B cells and T cells do not express detectable level of p120ctn. p120ctn isoform 1 
and 3 are observed most frequently among different cells. p120ctn isoform 4 contains the Arm 
domain without the N-terminal regulatory (phosphorylation) domain. In contrast to other isoforms, 
p120ctn isoform 4 mRNA has been detected, but is rarely expressed as a protein [18, 22]. 
The expression level and pattern of p120ctn isoforms can be changed in the cells in 
response to variant factors. Heterogeneous expression patterns of p120ctn isoforms in human 
tumor cells revealed the association between functions and p120ctn isoforms [22]. Some poorly 
differentiated tumor cells failed to express particular p120ctn isoforms which were typically 
observed in well-differentiated cell lines. Hence, the distinct expression pattern of p120ctn 
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isoforms in human tumors might contribute to malignancy, which may partially result from its 
functions in stabilization and regulation of membrane cadherins [22]. For example, different 
p120ctn isoforms showed a dramatic effect on the morphology of human pancreatic tumor cells 
(S2-013 cells) in culture.  S2-013 cells originally expressed very low level of p120ctn and showed 
a moderate mesenchymal morphology. Re-expression of p120ctn 1A enhanced the mesenchymal 
phenotype with cells exhibiting elongated shapes and increased cell motility within the monolayer. 
Re-expression of p120ctn 3A and 4A induced epithelial changes in cell morphology [23]. Based 
on those observations, cell type-dependent expression of p120ctn isoforms is correlated to the cell 
morphology and functions. Different isoforms may regulate cadherin complex functions by 
recruiting distinct binding partners or signaling molecules to the cadherin complex in response to 
variant stimuli. The regulated expression of multiple p120ctn isoforms might provide a mechanism 
for fine-tuning the activities of cadherins in different cell types. 
1.1.2 Structure of p120 catenin 
p120ctn consists of four distinct functional regions, including a N-terminal coiled-coil 
domain, a regulatory or phosphorylation domain, an Arm domain containing ten armadillo repeats 
and a short C-terminal tail (Figure 1.2).  The coiled-coil domain is only present in the long isoform 
(isoform 1). N-terminal regulatory domain is present in all except the shortest isoform (isoform 4). 
All p120ctn isoforms contain a central Arm domain, a repeating ∼46 amino acid motif composed 
of three α-helices, which was first characterized in the Drosophila segment polarity protein 
Armadillo Tandem [2]. Armadillo repeat units fold together as a superhelix, which provides a 
versatile platform for interactions with other protein partners [24]. p120ctn interacts via its central 
Arm domain with its partners including cadherins, RhoA, transcription factor Kaiso and 
microtubules [25]. The N-terminal regulatory domain is important for signal integration. It 
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contains multiple tyrosines, serines and threonines which can be modified by tyrosine kinases and 
serine/threonine kinases, as well as phosphatases. In addition to being a substrate for the kinases 
and phosphatases, p120ctn can also bind to and regulate the function of non-receptor tyrosine 
kinases such as Fer, Fyn and Yes, and the tyrosine phosphatases PTPμ and SHP-1 [25].  
1.1.3 Functions of p120 catenin 
Stabilization of adherens junction by association with cadherins 
Cadherins comprise a superfamily of transmembrane cell–cell adhesion molecules 
involved in tissue development, morphogenesis, wound healing, and tumor malignancy [26, 27]. 
The extracellular domains of cadherins interact in a homophilic and Ca2+-dependent fashion to 
form adherens junctions between adjacent cells. The cytoplasmic domains interact with the 
catenins.  C-terminal catenin binding domain interacts with α-, β- and γ-catenin, which bridge and 
regulate the interaction of the cadherin complex with the actin cytoskeleton [10, 28]. Cadherins 
bind through the juxtamembrane domain to the Arm domain of p120ctn (Figure1.1) [15, 29]. In 
cadherin-deficient cell model systems, p120ctn-uncoupled E-cadherin mutants failed to induce the 
strong cell adhesion observed in cells transfected with wild-type E-cadherin [29, 30]. Moreover, 
the dissociation of p120ctn from the cadherin complex resulted in endocytic internalization of 
cadherins [12, 31, 32]. Endocytosis of cadherins has been observed in cells during development, 
epithelial to mesenchymal transitions, and in response to growth factors and tumorigenic signaling 
agonists [33-35]. E-cadherin trafficking plays a pivotal role in E-cadherin-mediated cell–cell 
adhesions. Endocytosed cadherins can be either degraded in the lysosomes, or recycled to the 
plasma membrane via a process that involves p120ctn and Rap1 GTPase [36, 37]. p120ctn binding 
to the cadherin regulates cadherin membrane levels by preventing cadherin endocytosis. The 
structure of p120ctn in association to E-cadherin revealed that both “dynamic” and “static” 
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interactions contribute to the binding of p120ctn Arm domain with the cadherin JMD. The residues 
of E-cadherin involved in this interaction are also implicated in clathrin-mediated endocytosis and 
Hakai-dependent ubiquitination of E-cadherin [14]. Thus, p120ctn binding to cadherin physically 
impedes the interaction of cadherin with either clathrin or E3 ligases, which results in suppression 
on cadherin endocytosis and degradation [38, 39]. p120ctn may also serve as a scaffold for 
molecules which directly regulate the functions of cadherin/catenin complex proteins. For 
example, p120ctn can recruit a number of kinases and phosphatases that could affect the formation 
and stability of adherens junctions by changing the phosphorylation status of the entire 
cadherin/catenin complex, including p120ctn itself [34, 40]. Thus the membrane-associated 
p120ctn is a master regulator which is responsible for stabilizing cadherin expression at the plasma 
membrane and maintaining the structure of adherens junctions [41].   
  Regulation of Rho GTPase signaling 
 Rho GTPases (such as RhoA, Rac and Cdc42) are a subgroup of the Ras superfamily of 
small GTP-binding proteins that are involved in regulating a wide spectrum of cellular functions. 
They act as intracellular switches that control multiple signaling cascades by switching between 
active GTP-binding and inactive GDP-binding states. Exchanges in the GTP- and GDP-state cycle 
are generally regulated by guanine nucleotide dissociation inhibitors (GDIs), GTPase-activating 
proteins (GAPs) and guanine nucleotide exchange factors (GEFs). GDIs associate with GDP-
bound Rho GTPases to prevent their membrane-association and thus sequester them in an inactive 
state. GEFs activate Rho GTPases by catalyzing nucleotide exchange from GDP to GTP. GAPs 
inactivate Rho GTPase by promoting GTP hydrolysis. In their active state, Rho-GTPases interact 
with over 60 different target effectors [42]. Rho GTPases and their effectors are mediators of 
cytoskeletal dynamics [43] and cadherin-mediated adhesion [44-47] by transducing extracellular 
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signals to the actin cytoskeleton. They play important roles in regulating cell migration, motility 
and morphology [48, 49]. They also regulate gene transcription by activating MAPK and NF-κB 
signaling pathways [50-55].  
 RhoA, Rac and Cdc42 are the most well studied members of Rho GTPases.  Initial 
experiments demonstrated that p120ctn can inhibit RhoA and activate Rac and Cdc42, resulting in 
disruption of stress fibers and focal adhesions, as well as promoting migration of cells [56-58]. 
The interaction of p120ctn with Rho GTPase extends the effects of p120ctn to additional events, 
including cell survival, growth, and invasiveness because of Rho GTPase-mediated signaling 
cascades. Strong evidence revealed that cytosol p120ctn acts mainly through its direct interaction 
with RhoA. The mechanism by which p120ctn inhibits RhoA was revealed by in vitro GTP 
exchange assays.  It suggested that p120ctn could inhibit the intrinsic GDP/GTP exchange activity 
of RhoA in a manner comparable to that of GDI [57]. The direct interaction between p120ctn and 
RhoA sequesters RhoA in an inactive GDP-bound state.  Two domains of p120ctn have been 
identified being essential for the inhibitory interaction with RhoA: a central region (including 
amino acids 622-628) [57, 59] and an N-terminal region (including amino acids 131-156) [60, 61]. 
The interaction of p120ctn with RhoA is regulated by phosphorylation of p120ctn. For example, 
the interaction is promoted via tyrosine phosphorylation of p120ctn at Tyr217 and Tyr228 by Src, 
or destabilized by phosphorylation at Tyr112 by Fyn [61]. 
p120ctn could activate Cdc42 and Rac1, which might result from its interaction with the 
guanine nucleotide exchange factor Vav2 [58]. The activation of Rac1 by p120ctn might be 
another mechanism involved in its inhibitory effect on RhoA, since activated Rac1could inhibit 
RhoA activities indirectly in some cells via reactive oxygen species (ROS), p190 RhoGAP and 
cadherin homophilic ligation [62-64].  
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Regulation of gene transcription via interaction with Kaiso 
p120ctn is also a regulator of gene transcription via its interaction with transcription 
suppressor Kaiso. Kaiso binds to both a specific consensus Kaiso binding site (TCCTGCNA) and 
methylated CpG dinucleotides within target gene promoters [65]. Kaiso mediates DNA 
methylation-dependent transcriptional repression through its interaction with the nuclear receptor 
corepressor (NCoR) [66, 67]. p120ctn is capable of  nucleocytoplasmic trafficking  since it  has 
both nuclear localization signal  and nuclear export signal [68, 69]. Its interaction with zinc finger 
domain of Kaiso interrupts Kaiso-DNA binding, followed by translocation and sequestration of 
Kaiso into cytosol. The promoters of some Wnt/β-catenin target genes contain the sequence-
specific binding sites for Kaiso. Kaiso acts as a transcriptional repressor to antagonize β-catenin-
mediated transcriptional activation [70, 71]. Hence the interaction of p120ctn with Kaiso could 
facilitate Wnt/β-catenin signaling. Interestingly, Wnt signaling also affects transcriptional activity 
of Kaiso by regulating the phosphorylation and degradation of p120ctn [72]. Like β-catenin, 
p120ctn could transport into nucleus to regulate gene expression. However, the signals that trigger 
p120ctn nucleocytoplasmic trafficking has not been very clear. The transmembrane adhesion 
protein Mucin-1 might be one of the triggers for p120ctn nuclear localization [73]. 
1.1.4 Phosphorylation of p120 catenin 
p120ctn is an efficient substrate for tyrosine kinases and serine/threonine kinases [1, 74, 
75]. N-terminal regulatory domain contains multiple sites identified for phosphorylation by 
tyrosine kinases and serine/threonine kinases. p120ctn is highly tyrosine phosphorylated in Src-
transformed cells [1, 4], and  in response to a group of growth factors including platelet-derived 
growth factor, colony-stimulating factor 1, epidermal growth factor [76, 77], hepatocyte growth 
factor [78, 79], and vascular endothelial growth factor (VEGF) [80]. Hence, p120ctn is a substrate 
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of both non-receptor- and ligand-activated transmembrane receptor tyrosine kinases. p120ctn is 
not tyrosine phosphorylated in cells expressing non-myristylated alleles of Src [1, 77] or in 
cadherin-deficient cells when p120ctn is residing in the cytoplasm. These studies indicated that 
p120ctn phosphorylation requires the recruitment of the kinases to the membrane and the intact 
structure of cadherin-catenin complex [30].  
The stability and dynamics of the adherins junction are regulated by protein tyrosine 
kinases and phosphatases which are able to modulate the phosphorylation state of adherins junction 
components such as -catenin and p120ctn. In some cell contexts the phosphorylation is associated 
with loss of epithelial differentiation and increased invasiveness in human cancer cells [78]. 
p120ctn regulates the stability of adherens junction not only through its direct interaction with 
cadherins, but also via its interactions with multiple non-receptor tyrosine kinases and 
phosphatases. Some non-receptor protein tyrosine kinases such as Fer and Fyn are constitutively 
associated with p120ctn which in turn is their substrate [81, 82]. Interfering with the Fer-p120ctn 
interaction would result in the disruption of adherins junction complex in areas of cell-cell contacts 
[83]. Tyrosine phosphorylation of p120ctn increases the binding affinity of Fer or Fyn to adherens 
junction complex [81]. Therefore, p120ctn is not only the major substrate for kinases but also plays 
as a scaffolding and regulatory protein in adherens junctions by recruiting tyrosine kinases and 
phosphatases which can further modulate α-catenin/β-catenin and β-catenin/cadherin interactions 
[81, 84].  
p120ctn is also found phosphorylated on Ser/Thr residues in different cell lines [85-87]. 
Multiple residues of serine and threonine of p120ctn have been identified as phosphorylation sites 
[88]. For example, Protein kinase C (PKC) can promote phosphorylation of Ser879, and 
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dephosphorylation of several sits, such as Ser268, Ser288, Thr310 and Thr916, which is associated 
with stabilization of cell–cell adhesion [88-91].   
  Significant dephosphorylation of p120ctn has been observed in endothelial cells in 
response to inflammatory agents, such as histamine, thrombin and lysophosphatidic acid [92, 
93], via PKC-dependent and PKC-independent pathways in modulating its serine/threonine 
phosphorylation. VEGF stimulates both tyrosine phosphorylation and serine/threonine 
dephosphorylation of p120ctn in endothelial cells. Histamine and activators of PKC have a similar 
effect to that of VEGF on phosphorylation of p120ctn. Since VEGF and histamine could increases 
vascular permeability, these studies suggested that the phosphorylation state of p120ctn may 
contribute to regulating vascular permeability via controlling cell–cell adhesion [94]. 
The functions of combinatorial phosphorylation of p120ctn have not been very clear. A 
systematic identification and subsequent mutational analysis of tyrosine and serine/threonine 
residues targeted by kinases and phosphatases might be possible to address the physiological role 
of phosphorylation of p120ctn. 
1.2 LPS/TLR4 mediated inflammation in macrophage 
1.2.1 Toll-like receptor 
Toll-like receptors (TLRs) are human homologue of the Drosophila toll protein which has 
been shown to induce the innate immune response in adult Drosophila [95]. TLRs are prototype 
of pattern-recognition receptors (PRRs) that can detect both pathogen-associated molecular 
patterns (PAMPs) from microorganisms, and danger-associated molecular patterns (DAMPs) from 
damaged tissues [96, 97]. They belong to the type-1 transmembrane receptor family and are 
evolutionarily conserved proteins among vertebrates and invertebrates [95, 98]. TLRs are 
characterized by multiple copies of leucine-rich repeats in the extracellular domain and a 
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cytoplasmic Toll/ interleukin-1 receptor homology (TIR) domain. Mammalian TLRs comprise a 
large family including 13 members. TLR1–9 are conserved between human and mouse.  TLR10 
is presumably functional in the human. TLR11-13 are functional in mouse [99]. TLRs primarily 
recognize invading pathogens and initiate an immediate innate immune response, followed by a 
long-lasting adaptive immune response. Activation of TLRs provokes a variety of immune 
responses, including the expression of proinflammatory cytokines such as interleukin (IL)-1 and 
IL-12, chemokines such as IL-8, and inflammatory effector substances such as nitric oxide (NO) 
[98].  
 TLR4 was first identified as the receptor recognizing lipopolysaccharide (LPS), a major 
component of the outer membrane of Gram-negative bacteria [100].  In addition to the recognition 
of LPS, TLR4 from various species could recognize several other components of pathogens such 
as mannuronic acid polymers from Gram-negative bacteria [101], teichuronic acid from Gram-
positive bacteria [102], and viral components such as the F protein of respiratory syncytial virus 
[102, 103]. It also binds to endogenous molecules, such as heat shock proteins [104, 105], type III 
extra domain A of fibronectin [106, 107] and saturated fatty acids [108, 109]. Hence, both 
exogenous pathogens and endogenous molecules produced during abnormal situations, such as 
tissue damage, are able to trigger TLR4-dependent pathways [110].  
 TLR4 can be detected in multiple types of tissue, such as lung, colon and spleen [111].  
Analyses of total RNA showed that the predominant TLR4 expressing cells are monocytes in 
human peripheral blood mononuclear cells (PBMCs) [112, 113]. Exposure of monocytes or 
macrophages to LPS or to proinflammatory cytokines increases the expression of TLR4 [111] . In 
addition, TLR4 expression may also be up-regulated by high concentration of glucose in human 
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monocytes, which revealed one of the possible mechanism associated with high glucose-induced 
NF-B activity and proinflammatory cytokine secretion [114].  
1.2.2 TLR4-mediated signaling pathways  
 TLR4 forms a complex on the cell surface with other proteins including CD14 and myeloid 
differentiation factor 2 required for ligand recognition and signal transduction in high efficiency 
[115-117]. LPS is initially bound in the serum by LPS binding protein which transfers LPS to 
CD14 [118]. Upon LPS binding at the cell surface, TLR4 receptors dimerize through interactions 
between their intracellular TIR domains, resulting in conformational changes. The subsequent 
signaling process involves the recruitment of TIR-domain-containing adapter molecules to the 
cytoplasmic tail of TLR4 cluster via homophilic interactions between the TIR domains, which 
provide a platform enabling the recruitment and activation of the downstream kinases. The further 
propagation of signals ultimately leads to the activation of specific transcription factors, such as 
activator protein 1 (AP-1) and NF-B, as well as inflammatory gene expression (Figure 1.3) [98].  
 Four TIR-domain-containing adapter molecules are recruited to mediate TLR4 signaling 
pathways: myeloid differentiation factor 88 (MyD88); TIR-domain-containing adapter protein 
(TIRAP); TIR-domain-containing adapter inducing interferon-β (TRIF), and TRIF-related adapter 
molecule (TRAM). Through these four adaptors, TLR4 initiates intracellular signaling by at least 
two major pathways (Figure 1.3): (1) MyD88-dependent/TIRAP–MyD88 pathway. Upon 
stimulation, MyD88 recruits a cytoplasmic adapter protein IL-1 receptor-associated kinase 
(IRAK). Activated IRAK then associates with tumor necrosis factor receptor-associated factor 6 
(TRAF6), resulting in the activation of two signaling pathways. One pathway leads to activation 
of AP-1 transcription factors through activation of MAPK cascade. Another pathway activates IκB 
kinase (IKK) complex. Activated IKK complex induces phosphorylation and subsequent 
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degradation of IκB, which leads to nuclear translocation of transcription factor NF-κB. MyD88-
depedent pathway regulates the activation of MAPK and NF-κB signaling, and the production of 
related inflammatory cytokines such as IL-1 and IL-12. (2) MyD88-independent TRIF–TRAM 
pathway, which activates the transcription factor interferon regulatory factor-3 (IRF3) that leads 
to the subsequent expression of the genes encoding type I interferons (IFNs) and co-stimulatory 
molecules. This TRIF–TRAM pathway also increases tumor necrosis factor (TNF)-α production 
and secretion. The subsequent binding of secreted TNF-α to its receptors leads to NF-κB 
activation.  Thus, the TRIF–TRAM pathway is also responsible for the late phase NF-κB activation 
through TNF-α signaling [99, 116, 119, 120].    
1.3 Autophagy 
Autophagy refers to the conserved catabolic process in which cytoplasmic components are 
delivered to lysosome for degradation [121, 122]. Three types of autophagy have been identified, 
including macroautophagy, microautophagy and chaperone-mediated autophagy. In 
macroautophagy, the cytoplasmic components are sequestered in the double-membrane vesicles 
(autophagosome), followed by fusion with the lysosome to form autolysosome where the cargo is 
degraded [123]. Microautophagy refers to cytosolic components being directly taken up by the 
lysosome through invagination of the lysosomal membrane [124]. Both macroautophagy and 
microautophagy are capable of engulfing large molecules and organelles through selective and 
non-selective mechanism. In chaperone-mediated autophagy, targeted proteins are translocated 
across the lysosomal membrane with chaperone proteins (such as heat shock cognate protein Hsc-
70) through the lysosomal membrane receptor lysosomal-associated membrane protein 2A 
(LAMP-2A), resulting in unfolding and degradation of the target protein [125].  
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 Autophagy occurs at low basal levels in cells to maintain homeostasis [126]. It is 
upregulated when cells suffer nutrient starvation and growth factor withdrawal, or undergo 
structural remodeling during developmental transitions, or remove the damaging cytoplasmic 
components during oxidative stress, infection and protein aggregate accumulation [121, 127]. 
Macroautophagy (henceforth referred to as ‘autophagy’) has been profoundly studied in various 
research areas since it plays important roles in both health and multiple diseases [128-130].  
1.3.1 Process of autophagy 
 Autophagy is initiated by formation of a curved membrane structure, phagophore, in the 
cytoplasm. The phagophore elongates to form a double-membrane structure named 
autophagosome by recruiting and accumulating additional proteins. A portion of the cytoplasm 
along with the cellular components is enclosed in the autophagosome which is further fused with 
lysosome to form an autolysosome. The enclosed cargo is then degraded via proteolysis. In order 
to study the molecular mechanism, the process of autophagy is divided into five stages described 
as initiation, elongation, maturation, fusion and degradation (Figure 1.4) [131]. The process of 
autophagy is mediated and regulated by several molecular complexes which are composed of 
proteins encoded by AuTophaGy-related (ATG) genes [132]. More than 30 products of these genes 
have been originally characterized in yeast, and many orthologs have subsequently been identified 
as autophagy-related proteins in higher eukaryotes [133, 134].  
Initiation and elongation 
During the initiation stage, the autophagic membrane forms a phagophore, and then 
elongates. Several different cellular organelles have been considered as the autophagic membrane 
source, including the endoplasmic reticulum (ER), Golgi, mitochondria and plasma membranes 
[135-138]. It's suggested that SNARE (soluble N-ethylmaleimide-sensitive factor attached protein 
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receptor) proteins  mediate homotypic fusion of phagophore precursors, which contributes to 
recruitment of proteins that enable subsequent maturation of autophagosome [139]. The initiation 
and elongation stages are mediated by two major steps of protein processing and conjugation 
(Figure 1.5). The mechanisms of both conjugation systems resemble protein ubiquitination with 
corresponding enzymes to the E1 and E2 in ubiquitin ligation. Atg12 is conjugated to Atg5 by 
Atg7 (an E1-like protein) and Atg10 (an E2-like protein). Atg5 interacts further with Atg16L1 to 
form Atg12–Atg5-Atg16L1 complex (also called the Atg16L1 complex), a multimeric complex 
through the homo-oligomerization of Atg16L1.  The Atg12–Atg5–Atg16L1 complex is recruited 
to the membrane to function as an E3-like ligase to mediate the lipidation of microtubule-
associated protein 1 light chain 3 (MAP1LC3/LC3, an ortholog of yeast Atg8) in the process 
assisted by Atg7 (an E1-like protein) and Atg3 (an E2-like protein). A pro-LC3 is first cleaved at 
C-terminus by Atg4 to generate LC3-I, followed by conjugation to the lipid 
phosphatidylethanolamine (PE) to form LC3-II (the lipid-conjugated form). LC3-II is anchored 
into the membrane of autophagosome to mediate the expansion and fusion of the isolated 
autophagic membrane [140, 141].  Furthermore, LC3 molecules form a platform on the autophagic 
membrane to influence autophagosome formation by mediating assembly and disassembly of 
protein complexes at the membrane. [142, 143].  
 Maturation, fusion and degradation  
The autophagosome may fuse with a late endosome to form an amphisome [144], or fuse 
directly with the lysosome to generate an autolysosome in mammals [145]. In yeast, the 
autophagosome fuses with the vacuole and then releases the inner vesicle termed an autophagic 
body [146]. The inner vesicle of the autophagosome, together with the sequestered cargoes, is 
degraded, followed by the release of the breakdown products into the cytosol for reuse [147, 148]. 
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Before the closure of the membrane of an autophagosome, the Atg proteins bound to the membrane 
dissociate from autophagosome. LC3-II is present on both sides of the phagophore and the early 
autophagosome. It is released from the outer membrane by Atg4-dependent deconjugation during 
autophagosome maturation [142].  Since LC3-II is found on the inner and outer surfaces of the 
autophagosome and remains bound to the membrane even after lysosomal fusion, LC3-II is widely 
used as a marker for identifying autophagosomes in cells [133].  
1.3.2 Signaling pathways for regulation of autophagy 
Several protein complexes containing Atg proteins are involved in the signaling 
responsible for initiation and elongation stages of autophagy. Different reasons for autophagy are 
mediated through various signaling pathways. One of the regulators is mammalian target of 
rapamycin (mTOR). mTOR is the major negative regulator that shuts off autophagy when the 
growth factors and nutrients are abundant [130]. The activity of mTOR depends on a variety of 
upstream signals that include the energy and nutrient status of the cells. In nutrient-rich conditions, 
mTOR interacts with the ULK1 kinase complex (ULK1-Atg13-FIP200 complex) and 
phosphorylates ULK1 and Atg13 to suppress autophagosome formation. Upon starvation, the 
ULK1 kinase complex is activated due to the inhibition of mTOR activity. Activated ULK1 
complex leads to the activation of Beclin-1/Vps34 complex which consists of Vps34 (the class III 
PI3 kinase) and Beclin-1 (a mammalian ortholog of yeast Atg6). The Beclin-1/Vps34 complex can 
also be activated by other proteins that interact with Beclin-1, including UV radiation resistance 
protein and Ambra-1 (activating molecule in Beclin-1-regulated autophagy protein 1) [149].  Once 
being activated, Beclin-1/Vps34 complex can further activate the Atg proteins, and phosphorylate 
phosphatidylinositol to generate phosphatidylinositol 3-phosphate which is an essential lipid 
component of the autophagosome [150-153]. The activity of Beclin-1 is inhibited by its interaction 
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with B-cell lymphoma/leukemia (Bcl)-2 or Bcl-XL. This interaction can be disrupted by 
phosphorylation of Bcl-2 and/or Beclin-1, or ubiquitination of Beclin-1.  For example, under the 
condition of nutrient starvation, the stress-activated JNK1 phosphorylates Bcl-2, which induces 
the dissociation of Bcl-2 from Beclin-1. Upon stimulation of TLR4, TRAF6 and the 
deubiquitinating enzyme A20 can also control the initiation of autophagy through regulating lysine 
(K) 63-linked ubiquitination of Beclin-1 [154]. Thus dissociated Beclin-1 can interact with other 
members of the autophagic machinery and induce autophagy [155]. Autophagy can be induced by 
some drugs such as rapamycin which inhibits mTOR activity [156]. 
LC3 is another regulating point of autophagy. Phosphorylation of LC3 by protein kinase A 
inhibits autophagy by suppressing recruitment of LC3 molecules to autophagosome [157]. It was 
also observed that both rapamycin and pathological inducers of autophagy can cause 
dephosphorylation of endogenous LC3, which further proved that phosphorylation of LC3 might 
be an important regulatory mechanism during autophagy [157].  
1.3.3 Selective autophagy 
The balance between the biosynthesis and the degradation of cellular components is of 
importance for normal cellular homeostasis and health [158]. Autophagy has been thought as an 
essential non-selective pathway for bulk degradation induced by nutrient deprivation [159, 160] . 
However, accumulating evidence has shown selective autophagy contributes to intracellular 
homeostasis in non-starved cells by selective degradation of components including aberrant 
protein aggregates, lipid droplets, dysfunctional and superfluous organelles and intracellular 
pathogens [161-164]. In selective autophagy, the cargo has to be specifically recognized and 
effectively tethered to a nascent autophagosome. Selectivity in autophagy is achieved by cargo 
receptor proteins, which are able to tether the selected cargo to a nascent autophagosome by 
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simultaneous interaction with both the cargo and LC3-family proteins on the isolation 
membrane of autophagosome [161]. The post-translational modifications such as protein 
ubiquitination,  have an important role in ensuring substrate recognition and selectivity [165].  The 
recognition of ubiquitinated substrates is achieved by molecular adaptors including p62, NBR1, 
NDP52, VCP and optineurin, which target ubiquitinated cargo to autophagy-associated proteins, 
such as the LC3 family members [166, 167].  
 A variety of cargo receptors are responsible for recognition of different cargoes. For 
example, in mammalian cells, nuclear receptor coactivator 4 (NCOA4) is the cargo receptor for 
ferritin during ferritinophagy [168].  Ferritin forms complex to sequester excessive intracellular 
iron [169]. Under conditions of low intracellular iron, NCOA4 receptor binds to ferritin heavy 
chains and deliver the ferritin complexes into the lysosomal compartment via selective autophagy 
[168, 170]. Degradation of ferritin in the lysosomes ultimately leads to the release of  iron  back 
into the cytosol [171].   
Another well-studied cargo receptor p62, also known as sequestosome 1 (SQSTM1) 
mediates the degradation of ubiquitinated molecules such as aggregated proteins or cytosolic 
bacteria [172, 173]. The cargo receptor p62 binds to ubiquitin through its ubiquitin-associated 
(UBA) domain with a relatively low affinity. The affinity of p62 for polyubiquitin chain is 
increased by phosphorylation of serine 403 within its UBA domain [174].  The N-terminal 
Phox/Bem 1 (PB1) domain of p62 mediates its homo-oligomerization. Oligomerization of p62 
stabilizes binding to the cargo material on which ubiquitin is concentrated [175]. Different 
ubiquitin chains trigger different cellular degradation processes. The preferential interaction of p62 
with certain types of ubiquitin chain might contribute to selectivity regulation during selective 
autophagy. K48-linked ubiquitin chains are recognized by the proteasome and therefore mediate 
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proteasomal degradation of the substrates. K63-linked ubiquitin chains are associated with 
selective autophagy [176, 177]. It has been shown that oligomeric p62 preferentially binds to K63-
linked ubiquitin chains, as well as mono-ubiquitin [178]. 
The selected cargoes target to a nascent autophagosome via the interaction between LC3-
family proteins and cargo receptors through their conserved LC3-interacting region (LIR) motif, 
also known as Atg8-interacting motif (AIM). The consensus for the core LIR motif is 
(W/F/Y)XX(L/I/V), where X is any other residue.  This sequence is surrounded by at least one 
acidic residue. Structural studies have revealed that the hydrophobic residues of the core LIR motif 
dock into two hydrophobic pockets in the ubiquitin-like domain of LC3, whereas adjacent acidic 
residues form electrostatic interactions with the N-terminal arm of LC3 molecules. The core LIR 
motif adopts an extended β-conformation and forms an intermolecular parallel β-sheet with the β2 
strand of  LC3 [179]. 
1.3.4 General functions of autophagy 
Autophagy has been found associated with a broad spectrum of biological processes 
including aging, development, degenerative diseases, and cancer [130, 180].  Autophagy is 
important in mammals for development and differentiation such as preimplantation [181], survival 
during neonatal starvation [159], as well as cell differentiation during erythropoiesis [182], 
lymphocyte differentiation [183, 184], and adipogenesis [185].   
Autophagy is also associated with the pathogenesis of various diseases. Tissue-specific 
knockout studies in mice indicate autophagy plays a critical role in intracellular protein and 
organelle quality control, which is associated with the pathogenesis of several genetic diseases 
including liver disease, neurodegenerative diseases, and myodegenerative diseases. They may be 
caused due to either the failure of autophagosomes to fuse with lysosomes or the aggregation of 
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misfolded proteins that exceed the autophagic clearance capacity [186-188]. Autophagy is also 
found associated with tumorigenesis. The expression of Beclin-1 has been found decreased in 
human breast, ovarian, and brain tumors [189, 190]. Gene transfer of Beclin-1 can inhibit the 
growth of tumor cell lines and the tumorigenicity of human breast carcinoma cells in mouse 
xenograft models [191, 192]. Thus, Beclin-1 might be a candidate of tumor suppressor, which is 
the first specific link between the autophagy and human cancer. Moreover, several tumor 
suppressors involved in the inhibition of mTOR signaling, such as phosphatase and tensin homolog 
(PTEN), tuberous sclerosis (TSC) 1, and TSC2, could stimulate autophagy [193]. Conversely, 
oncogene products such as class I PI3K and Akt could inhibit autophagy through activating mTOR. 
Tumor suppressor p53 regulates autophagy under genotoxic and other stresses [194].  
1.3.5 Autophagy in immunity 
The functions of autophagy in immunity have been profoundly studied recently [195]. 
Autophagy not only  maintains cellular homeostasis under conditions of endogenous distress,  but 
also plays a primordial role in controlling intracellular pathogens in different species from 
unicellular organisms to human [196]. Autophagy represents one of the most primitive examples 
of innate immune responses. In mammals, the functions of autophagy have evolved to incorporate 
into multiple pathways of innate and adaptive immunity, including  direct elimination of  
microorganisms [197, 198], as well as  regulating inflammation [199], MHC II-restricted 
endogenous antigen presentation [200, 201], lymphocyte homeostasis [202], the secretion of 
immune mediators [203], and  central tolerance [184]. The functions of autophagy in regulating 
immunity has been also proved by the evidence that autophagy contributes to chronic 
inflammatory diseases [204-206].  
Direct elimination of microorganisms 
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The antimicrobial functions of autophagy provide barriers against invading 
microorganisms. It includes xenophagy which is the selective uptake and degradation of 
intracellular microorganisms via autophagy [207], and LC3-associated phagocytosis which 
involves the engagement of the autophagic machinery as the bacterium is confined in the 
phagosome [208, 209]. Some invading microorganisms or the damaged host membranes 
associated with the pathogen express some molecular tags, such as ubiquitin, galectin and 
membrane phospholipid modifications. Those tags can be recognized by autophagy receptors 
which recruit the autophagic machinery and initiate autophagy [166, 210-212]. Autophagy-
associated proteins have been shown to directly target microbial proteins, such as Atg5 which can 
target surface protein VirG of bacteria Shigella and promote selective autophagy of bacteria [213].  
Regulation of innate immunity 
Many signals which can initiate immune response also induce autophagy, such as PAMPs 
[214-216], DAMPs (including ATP, ROS and misfolded proteins) [217], JNK [218], and IKK 
[219]. Pathogen can initiate autophagy at multiple stages [220]. Autophagy can be initiated during 
adhesion and uptake of bacteria by the host cells, or during phagocytosis of bacteria by 
macrophages [209, 214, 221]. After bacterial uptake, autophagy is induced by pathogen-inflicted 
cell damage or the intracellular bacteria [211-213, 222, 223]. The initiation of autophagy after 
virus infection occurs at different stages of the virus life cycle [224-228]. The proinflammatory 
cytokines, including IL-1, IL-2, IL-6, TNF-α, transforming growth factor-β and IFN-γ, can induce 
autophagy; whereas TH2 cell-associated cytokines, such as IL-4, IL-10, and IL-13, can inhibit 
autophagy [229, 230]. IL-1β could induce autophagy leading to autophagic elimination 
of Mycobacterium tuberculosis in macrophages, which was dependent on TANK-binding kinase 
1 (TBK-1) [231]. TBK1 is necessary for autophagic maturation and autophagic machinery 
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assembly. It can phosphorylate p62 on Ser403, which is essential for p62 in autophagic 
clearance.  IL-1β activates NF-B signal pathway through TRAF6 [232]  which is also involved 
in the activation of autophagy  via the subsequent TRAF6-dependent K63-linked ubiquitination of 
Beclin-1 [154].  
In response to infection, both innate and adaptive immune system are activated to control 
infection. At the same time some specific responses that limit detrimental immune activation and 
inflammation are also initiated.  Research on autophagy reveals autophagy proteins function in 
both the activation and inactivation of innate immune signaling, such as type I IFN signaling and 
inflammasome activation [220].  
The autophagy pathway can activate the production of type I IFN in plasmacytoid dendritic 
cells by delivering viral nucleic acids to endosomal TLRs [227]. Single-stranded RNA viruses are 
recognized by the RIG-I-like receptors (RLRs) in the cytosol. RLRs signaling results in the 
production of antiviral cytokine type I IFNs.  Atg5-deficient cells exhibited enhanced RLR 
signaling and increased IFN secretion.  In the absence of autophagy, accumulated dysfunctional 
mitochondria, as well as dysfunctional mitochondria-associated ROS were mainly responsible for 
the enhanced RLR signaling [233]. Double-stranded DNA (dsDNA) can also induce potent innate 
immune responses via the induction of type I IFN and IFN-inducible genes. Upon sensing dsDNA, 
stimulator of IFN genes (STING) moves from ER to the Golgi apparatus and finally to the 
cytoplasmic to assemble with TBK1. The translocation and assembly of the signal transducers, 
STING and TBK1, are required for dsDNA-triggered innate immune responses. However, STING 
also co-localizes with the autophagy protein LC3 and Atg9a after dsDNA stimulation. The loss of 
Atg9a greatly enhances the assembly of STING to TBK1 by dsDNA, resulting in aberrant 
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activation of the innate immune response. Thus autophagy could limit dsDNA-induced innate 
immune responses by regulating the assembly of STING and TBK1 [234].  
The inflammasomes are multiprotein complexes activated by infection or stress. 
Inflammasomes in immune cells are fundamental in the innate immunity against microbes. They 
are composed of nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) proteins 
and functions as signaling platforms for the activation of caspase-1 and subsequent maturation of 
the proinflammatory cytokines IL-1β and IL-18 [235]. The aberrant activation of inflammation is 
involved in the pathogenesis of autoimmune and inflammatory diseases , as well as metabolic 
disorders [236]. Several studies have revealed a link between autophagy and inflammasome 
activation, and the potential roles in disease progression [237-239]. For example, Atg16L1-
deficient mice suffer severe colitis induced by dextran sulfate sodium, which can be alleviated by 
neutralization of IL-18 and IL-1β. This research indicated that the severe colitis probably resulted 
from the enhanced inflammasome activity resulted from defective autophagy [199]. Activation of 
inflammasomes in macrophage could lead to autophagosome formation via the activation of small 
G protein RalB, a direct trigger of autophagosome formation. Activated autophagy is able to recruit 
p62 and then target ubiquitinated inflammasomes for degradation via autophagy [240]. Hence, 
autophagy and inflammasome activation are mutual regulated. 
In addition to directly regulating inflammatory signaling, the autophagy pathway might 
prevent tissue inflammation through its role in apoptotic corpse clearance. The efficient clearance 
of apoptotic cells prevents secondary necrosis and excess inflammation triggered by released 
danger signals from dead cells. Mice lacking Atg5 display a defect in apoptotic corpse engulfment 
during embryonic development. Autophagy contributes to the clearance of dead cells by a 
mechanism that involves the generation of ATP-dependent engulfment signals [241]. Involution 
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is the process of post-lactational mammary gland regression which involves the death of secretory 
epithelial cells and stroma remodeling. It was revealed that Beclin-1- or Atg7-deficient mammary 
epithelial cells were defective in engulfment of apoptotic bodies, which resulted in higher levels 
of involution-associated inflammation in Atg-deficient tissues. Beclin-1 or Atg7 knockdown could 
compromise apoptotic body clearance. One possible mechanism is associated with decreased 
activation of GTPase Rac1 which mediates actin reorganization and phagocytic cup formation for 
effective dead cell engulfment [242].  
Autophagy in adaptive immunity 
Autophagy is also a cell biological pathway affecting adaptive immune responses. Studies 
revealed that dendritic cells utilize autophagy machinery for optimal phagosome-to-lysosome 
fusion and subsequent processing of antigen for MHC class II loading [243]. Another study 
indicates that autophagy-dependent antigen presentation is defective in dendritic cells with Crohn's 
disease-associated Atg16L1 risk variants [221].   
In addition to its role in antigen presentation, autophagy affects both the homeostasis and 
the functions of T cells. Autophagy and clearance of mitochondria are required for normal 
haematopoietic stem cell maintenance and function [244]. After exiting the thymus, naive T cells 
depend on autophagy and mitochondrial content reduction for their maturation [183]. Autophagy 
also has a role in the selection of naive T cell repertoires in the thymus. Thymic epithelial cells 
had a high level of constitutive autophagy. Atg5 deficiency in thymic epithelial cells led to altered 
selection of MHC-II-restricted T-cell specificities and resulted in severe colitis and multi-organ 
inflammation. These effects have been attributed to the defective presentation of cytoplasmic 
antigens by autophagy-deficient thymic epithelial cells [184].  Autophagy is also involved in the 
NF-κB activation in antigen-activated T cells. The adaptor protein Bcl-10 is a mediator of T cell 
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receptor (TCR)/NF-κB signaling. TCR activation promotes K63 polyubiquitination of Bcl-10, 
followed by Bcl-10 association with the autophagy adaptor p62. p62 binding was required for both 
Bcl-10 signaling to NF-κB and gradual degradation of Bcl-10 by autophagy. The blockade of Bcl-
10 degradation via autophagy can enhance TCR activation of NF-κB. Hence, selective autophagy 
is involved in the degradation of Bcl-10, which can reduce NF-κB activation by TCR in antigen-
activated T cells [245].     
Autophagy is required for plasma cell homeostasis and long-lived humoral immunity. Mice 
with conditional deficiency of Atg5 in B cells showed plasma cells had a larger ER and more ER 
stress signaling which led to more antibody secretion and fewer antigen-specific long-lived bone 
marrow plasma cells. The enhanced antibody synthesis was associated with lower level of 
intracellular ATP and more death of mutant plasma cells. Autophagy reduces immunoglobulin 
secretion from plasma cells, which seems to be a mechanism preventing excessive antibody 
production [246]. 
Autophagy and inflammatory disease 
Perturbations in autophagy-dependent functions in immunity contribute not only to 
increased susceptibility to infection, but also to chronic inflammatory diseases and autoimmune 
diseases. The well-characterized link between autophagy and inflammatory disease is the 
variations in autophagy proteins in association with Crohn's disease, a chronic inflammatory 
disorder of the intestine [247]. Other emerging associations include the autoimmune diseases such 
as systemic lupus erythematosus (SLE) [248] , and inflammation-associated metabolic disorders 
such as obesity and diabetes [249, 250].   
Genome-wide association studies identified that Crohn's disease susceptibility genes, such 
as Atg16L1, are involved in autophagy [247]. Antigen presentation has been found defective in 
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dendritic cells from patients with the Crohn's disease-associated Atg16L1 risk variant [221]. 
Studies using mouse model with Atg16L1 mutation further proved that defective autophagy is 
relevant to pathogenesis of Crohn's disease. Loss of Atg16l1 function in mice results in enhanced 
proinflammatory cytokine production by macrophages induced by TLR agonists [199], enhanced 
chemical-induced colitis [199, 251] and altered inflammatory gene transcriptional profiles in 
Paneth cells [205, 251].  
 Genome-wide association studies have also linked several single nucleotide 
polymorphisms in Atg5 to SLE susceptibility [248, 252, 253]. SLE is characterized by 
autoimmune responses against self-antigens. Autophagy protein Atg5 is critical for T-cell selection 
which is responsible for the generation of a self-tolerant T-cell repertoire in thymus. Atg5-depleted 
thymic epithelial cells are defective in negative thymic selection, resulting in generation of 
autoimmunity and multi-organ inflammation in mice [184]. Other Atg5-dependent effects, 
including regulation of IFN and proinflammatory cytokine secretion [233, 254], clearance of dying 
cells [254] and dendritic cell antigen presentation [243], might also be relevant to the 
autoimmunity and inflammation associated with SLE. 
Defects in autophagy may contribute to some metabolic diseases, such as diabetes and 
obesity, which are linked to inflammation and insulin resistance [255]. Hepatic suppression of 
Atg7 in mice results in increased ER stress and insulin resistance [249].  p62 deficient mice 
develop mature-onset obesity and insulin resistance [250]. Thus, the defective autophagy-
dependent regulation of ER stress, as well as immune cell homeostasis and activation may 
contribute to inflammatory responses that underlie the pathogenesis of metabolic diseases [196].  
1.4 p120 Catenin in inflammation 
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 The evidence that p120ctn might be involved in the regulation of inflammation was first 
observed in p120ctn knockout animal models. Conditional knockout of  p120ctn  in mice results 
in a chronic inflammatory response in intestines [256, 257] and epidermis [258, 259], which 
is characterized by tissue infiltration of immune cells including lymphocytes, mast cells, 
granulocytes, and macrophages, as well as expression of pro-inflammatory cytokines, such as  
TNF-α,  IL-1β, IL-6, macrophage inflammatory protein 3 α (MIP3α), and macrophage chemotactic 
protein 1 (MCP1), even in the absence of exogenous inflammatory stimuli. In human endothelial 
cells, depletion of p120ctn increased transcription factor activities (including NF-κB, AP-1, and 
Kaiso), adhesion molecules expression, neutrophil adhesion, and Erk1/2 signaling 
[260]. Overexpression of p120ctn in human umbilical vein and dermal microvascular endothelial 
cells inhibited neutrophil transendothelial migration [261]. p120ctn-depleted epidermal cells have 
elevated activities of NF-κB, which triggers a cascade of proinflammatory responses both in 
vivo and in vitro. The activation of RhoA/Rho-associated protein kinase (ROCK) pathway 
resulting from the loss of p120ctn might be partially responsible for NF-κB over-activation and 
proinflammatory cytokine production [259]. There is also a significant correlation between 
p120ctn loss and increased incidence of inflammatory bowel disease in both human patients and 
mouse models [257, 262]. Multiple researches demonstrated that p120ctn depletion could cause a 
chronic inflammatory response which might be mediated by the mechanism that does not require 
some specific exogenous stimuli under some circumstances.  
  Immune functions of p120 catenin in LPS/TLR4-dependent inflammatory response 
  p120ctn knockdown alone in mouse lung endothelial cells did not significantly affect NF-
κB activation but enhanced LPS-induced NF-κB activation, which suggests an important role of 
endothelial p120ctn in the regulation of LPS/TLR4-dependent NF-κB signaling. In LPS-induced 
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lung injury mouse model, p120ctn was rapidly degraded in response to LPS challenge. Moreover, 
the level of p120ctn was correlated inversely with the severity of lung inflammation. Hence, 
endothelial p120ctn degradation during endotoxemia might be one of the reasons for the 
amplification of pulmonary inflammation.  Depletion of p120ctn in pulmonary endothelial cells 
could increase the sensitivity to LPS and induced inflammatory response characterized by 
increased production of proinflammatory cytokines (such as TNF-α and IL-6), elevated neutrophil 
infiltration into the lung, hyperpermeability of pulmonary vasculature. In contrast, overexpression 
of p120ctn could suppress those LPS-induced effects [263]. Hyperpermeability of pulmonary 
vasculature induced by LPS might be associated with LPS-induced tyrosine phosphorylation of 
VE-cadherin, γ-catenin, and p120ctn through Src family tyrosine kinases [264]. Therefore, 
endothelial p120ctn may be a negative regulator of sepsis-induced lung inflammatory injury. 
 p120ctn can also regulate LPS/TLR4 signaling by facilitating TLR4 endocytic trafficking 
in mouse bone marrow-derived macrophages. p120ctn silencing could diminish LPS-induced 
TLR4 internalization.  Genetic and pharmacological inhibition of RhoA could rescue the decrease 
in endocytosis of TLR4 and TLR4-MyD88 signaling in p120ctn null cells. This might be another 
reason for LPS-induced over-inflammatory response in p120ctn-depleted cells [265].  
p120 Catenin regulating inflammation via RhoA/ROCK-dependent signaling 
RhoA/ROCK signaling associates with the activation of IKK/NF-κB [266, 267]. Since 
cytosol p120ctn can interact with RhoA and inhibit its activation, RhoA/ROCK pathway would be 
one of the mechanism to explain how p120ctn regulates NF-κB-mediated inflammatory response. 
In mouse p120ctn-depleted epidermis, chronic inflammation and increased NF-κB activity were 
observed even without specific stimuli [259].  Re-expression of wild-type p120ctn, overexpression 
of dominant-negative RhoA or inhibition of ROCK reduced NF-κB activity. In contrast, 
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expression of a mutant form of p120ctn (Δ622–628) which is unable to bind to RhoA failed to 
suppress NF-κB activity. Expression of a cadherin-uncoupled p120ctn mutant in keratinocytes still 
could reduce NF-κB activity, suggesting that cadherin binding is not required for the ability of 
p120ctn to inhibit NF-κB activity in human epidermis [259].  
1.5 Hypotheses of this study 
p120 Catenin suppresses LPS-induced inflammatory response via its inhibitory effects on 
NF-κB pathway activation in THP-1 derived macrophages. Decreased autophagy is associated 
with abnormal proinflammatory reactions in p120 catenin-depleted macrophages in response to 
LPS stimulation.  
1.6 Specific aims of this study: 
1. To examine the expression of p120 catenin in THP-1 derived macrophages in response to 
LPS challenge. 
2. To study the functions of p120 catenin in NF-κB signaling in THP-1 derived macrophages 
in response to LPS challenge. 
3. To investigate the effects of p120 catenin depletion on LPS-induced autophagy in THP-1 
derived macrophages.  
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Antibodies and reagents  
Anti-human p120 catenin (G7) (targeting N-terminus) and Na+/K+ ATPase antibodies 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); Antibodies including 
anti-phosphorylated and total Erk, p38, JNK, Akt, Src, IKK, and NF-κB p65 were from Cell 
Signaling Tecnology (Danvers, MA, USA). Anti-IκBα, LC3, Atg3, Atg7, Atg12, Atg16L1 and 
lamin B1 antibodies were purchased from Cell Signaling Tecnology (Danvers, MA, USA). 
Anti-p62 antibody was acquired from Abcam (Cambridge, MA, USA). Anti-GAPDH 
antibody, M-PER protein extraction reagent and subcellular protein fractionation kit were 
purchased from Thermo Fisher Scientific (Waltham, MA, USA). RPMI 1640 media, HEPES 
and fetal bovine serum (FBS) were obtained from Thermo Scientific HyClone (Logan, UT, 
USA). LPS (Escherichia coli, O111:B4, and Pseudomonas aeruginosa 10), phorbol 12-
myristate 13-acetate (PMA) and MG132, goat serum were acquired from Sigma-Aldrich (St. 
Louis, MO. USA). Bafilomycin A1 was acquired from Cell Signaling Tecnology (Danvers, 
MA, USA). PP2 was purchased from Cayman (Ann Arbor, MI, USA). Lentivirus p120ctn 
shRNA and control shRNA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). PCR primers for cytokines and p120ctn isoforms were synthesized by Sigma-Aldrich 
(St. Louis, MO. USA). ReliaPrep™ RNA Cell Miniprep System was from Promega (Madison, 
WI, USA). ProtoScript II reverse transcriptase, murine RNase inhibitor, dNTP mix and 
TopTaq DNA polymerase were from New England Biolabs (Ipswich, MA, USA). Laemmli 
sample buffer and Clarity Western ECL reagents were purchased from Bio-Rad Life Science 
(Hercules, CA, USA).  
2.2 Cell culture 
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Human monocytic THP-1 cells were obtained from the ATCC (TIB-202TM). THP-1 cells 
were cultured in RPMI 1640 medium containing 10% of FBS, 10 mM HEPES, 50 µM ß-
mercaptoethanol, 100 U/ml penicillin and 100 μg/ml streptomycin. THP-1 monocytes were 
differentiated into THP-1 derived macrophages (TDMs) by culturing with 10 ng/ml phorbol 12-
myristate 13-acetate (PMA) in RPMI 1640 medium containing 10% of FBS and 10 mM HEPES 
for 3 days. TDMs were then treated with other reagents after cultured in RPMI 1640 medium 
without PMA overnight. Lung cancer cell lines A549 and Calu-3 cells were from ATCC. A549 
cells were cultured in RPMI 1640 medium containing 10% of FBS, 100 U/ml penicillin and 100 
μg/ml streptomycin. Calu-3 cells were cultured in DMEM/F12 medium containing 10% of FBS, 
100 U/ml penicillin and 100 μg/ml streptomycin. 
2.3 p120 Catenin knockdown inTHP-1 cells  
Lentivirus p120ctn shRNA and control shRNA were used to knock down p120ctn 
expression in THP-1 cells. Stable p120ctn knockdown THP-1 cell line was selected with 1 μg/ml 
puromycin for 3 days. p120ctn knockdown THP-1 cells were further differentiated to macrophages 
with PMA. The expression of p120ctn was tested via PCR and Western blot. 
2.4 Western blot 
Culture cells were lysed with M-PER protein extraction reagent after washed with cold 
PBS twice. The total proteins were resolved by SDS-PAGE, followed by transfer to polyvinylidene 
fluoride membranes. The membranes were then blocked with 1% goat serum, followed by 
overnight incubation with antibodies anti-target proteins at 4°C and then with goat anti-
mouse/rabbit IgG at room temperature for 1 hour. The protein bands were visualized by using 
Clarity Western ECL reagents.  
2.5 p120 Catenin isoform identification  
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p120ctn isoforms were identified via reverse transcription PCR (RT-PCR) and Western 
blot. Total RNA was isolated from the cells using ReliaPrep™ RNA Cell Miniprep System, in 
accordance with the manufacturer’s recommendations. The total RNA was then synthesized to 
cDNA by reverse-transcription. PCR was used to identify the isoforms of p120ctn expressed in 
THP-1 and THP-1 derived macrophages by using specific primers targeting different mRNA 
variants. The primers and the PCR conditions were described previously (Table 2.1) [268]. 
GAPDH was used as internal control. The products were analyzed on a 1-2% agarose gel and 
compared to a 100 bp DNA ladder. The protein expression was analyzed using Western blot.  
Epithelial cells A549 and Calu3 were used as control. 
2.6 Expression and distribution of p120ctn in macrophages upon LPS stimulation. 
TDMs were stimulated with LPS (both E. coli and P. aeruginosa) in RPMI 1640 medium 
containing 5% of FBS and 10 mM HEPES for indicated time points. Total protein was extracted 
with M-PER protein extraction reagent. Subcellular proteins, including membrane, cytosolic and 
nuclear protein, were prepared by using Subcellular protein fractionation kit. Western Blot was 
then used to test the total expression and subcellular localization of p120ctn in macrophages upon 
LPS stimulation for indicated time intervals. Relative protein levels were compared in reference 
to internal controls including Na+/K+ ATPase, GAPDH, and lamin B1. The macrophages were 
pretreated with Src inhibitor PP2 (10 μM) for 30 minutes, followed by stimulation with 1 μg/ml of 
LPS (E. coli O111:B4) for 2 hours. The total p120ctn expression was tested via immunoblot.  To 
test the pathways responsible for p120ctn degradation, the macrophages were stimulated with 1 
μg/ml of LPS (E. coli O111:B4) for 30 min, followed by treatment with or without bafilomycin 
A1 (1 μM) or MG132 (10 μM) for 2 hours (LPS was not removed). The total p120ctn expression 
was tested via immunoblot.   
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2.7 Analysis of proinflammatory cytokine expression 
p120ctn knockdown and control macrophages were stimulated by 100 ng/ml of LPS in 
RPMI1640 medium containing 5% FBS for indicated time. Proinflammatory cytokines (IL-1β, IL-
8, IL-6 and TNF-α) were examined  by RT-PCR. PCR primers and conditions were described in 
Table 2.2. 
2.8 Activation of signaling pathways 
Macrophages were cultured in RPMI 1640 medium containing 1% FBS overnight, 
followed by stimulation with LPS for indicated time. Activation of signaling pathways, including 
NF-κB, MAPK, Src and Akt pathways, was investigated by immunoblot.  
2.9 LPS-induced autophagy  
THP-1 derived macrophages were stimulated with 100 ng/ml of LPS (E. coli, O111:B4) in 
RPMI1640 medium containing 5% FBS for indicated time. LC3, P62 and Atgs were tested by 
Western blot. In order to test autophagy flux, the macrophages were stimulated with 100 ng/ml of 
LPS (E. coli O111:B4) for 8 hours, followed by treatment with or without bafilomycin A1 (1 μM) 
for 1 hour. LC3 and p62 were tested by Western blot.  
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CHAPTER 3 RESULTS 
3.1 Establishment of macrophage cell model. 
THP-1 cells, a human monocytic cell line, were induced to differentiate into THP-1 derived 
macrophages after exposure to PMA for 3 days. During the differentiation,  suspension THP-1 
monocytes adhered to culture plates accompanied by differentiating into a macrophage phenotype: 
flat, spreading and amoeboid in shape (Figure 3.1A). Prior to examing p120 catenin functions, 
THP-1 derived macrophages were stimulated with 1 μg/ml of  LPS (P. aeruginosa 10) for 12 and 
24 hours.  mRNA expression of proinflammatory cytokines including IL-1β, IL-8 and TNF-α was 
tested via RT-PCR. mRNA level of IL-1β, IL-8 and TNF-α was significantly increased in 
macrophages upon LPS stimulation (Figure 3.1B). 
3.2 p120 Catenin isoforms in macrophages 
p120ctn has multiple isoforms due to alternative splicing. In order to identify the isoforms 
expressed in THP-1 monocytes and mcrophages, RT-PCR was used to analyze the mRNA 
expression of p120ctn isoforms, using specific primers targeting different mRNA variants of 
isoforms. Lung cancer cell lines A549 and Calu-3 were used as control. In combination with  the 
protein bands analyzed via Western blot, THP-1, THP-1 derived macrophages, and A549 expressd 
isoform 1A and 3A, whereas Calu-3 expressed isoform 3A and 3AB. The protein levels of two 
isoforms were similar in macrophages (Figure 3.2 and Table 3.1 ).  
3.3 p120 Catenin expression in macrophages in response to LPS stimulation. 
The expression of p120 catenin in THP-1 derived macrophages was determined by Western 
blot analysis following stimulation of LPS. p120ctn protein level was reduced in a time-dependent 
manner following E. coli LPS challenge, whereas p120ctn expression in macrophages was not 
changed significantly after P. aeruginosa LPS stimulation (Figure 3.3A). p120ctn decreased to the 
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lowest level within 4-hour treatment of LPS from E. coli and then gradually recovered within 24 
hours after LPS exposure (1 g/ml). The effects of LPS (E. coli) on p120ctn mRNA expression 
was examined by RT-PCR and no significant difference was observed (Fig. 3.3B). These results 
suggest that the rapid loss of p120ctn after LPS (E. coli) challenge might be due to the enhanced 
degradation of p120ctn protein. Next, the proteasome inhibitor MG132 and autophagy inhibitor 
bafilomycin A1 were used to identify the pathways for degradation of p120ctn protein in 
macrophages following LPS challenge. The loss of p120ctn protein following LPS treatment was 
not suppressed in macrophages after inhibition of proteasomal pathway, whereas p120ctn 
degradation after LPS stimulation was inhibited by autophagy inhibitor bafilomycin A1. Thus 
these results indicate that the autophagic pathway might be the major mechanism responsible for 
p120ctn protein degradation in macrophages following E. coli LPS challenge (Fig. 3.3C). The total 
protein of p120ctn was not significantly changed in macrophages after stimulation with P. 
aeruginosa LPS. Therefore, the subcellular distribution of p120ctn protein was analyzed and no 
significant change was observed in macrophages after P. aeruginosa LPS treatment (Figure 3.3D). 
3.4 Activation of MAPK and NF-B signaling pathways in THP-1 derived macrophages after 
LPS treatment. 
Since LPS from E. coli and P. aeruginosa could induce different effects on p120ctn protein 
expression in macrophage, the signaling pathways were compared in macrophages upon both LPS 
(1 g/ml) stimulation. Both LPS could activate MAPK pathways including Erk, p38 and JNK, and 
no significant difference was observed in the activation pattern of these signaling pathways in 
macrophages after both LPS stimulation (Figure 3.4, A and B). The basal level of activated Akt 
was very high and the activation of Akt was not very strong in THP-1 derived macrophages 
following stimulation of LPS from both E. coli and P. aeruginosa (Figure3.4, A and B). The 
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activation of NF-B signaling pathway was also examined in macrophages upon LPS stimulation. 
As the Figure 3.4, C and D showed, the time-dependent pattern of IKK activation and IB 
degradation was similar in macrophages after treatment with LPS from both E. coli and P. 
aeruginosa. 
3.5 Src signaling responsible for the degradation of p120 catenin in THP-1 derived 
macrophages upon LPS stimulation 
There are two major phosphorylation sites on Src: Tyr416 and Tyr527. Tyr416 
phosphorylation activates Src by allowing the substrate to gain access to the catalytic domain. 
Phosphorylation of Tyr527 inactivates Src through changing Src conformation into a closed 
inaccessible bundle [269]. Upon E. coli LPS stimulation, Src was phosphorylated at Tyr416 
(Figure 3.5B), whereas the phosphorylation of Src Tyr416 was not observed in macrophage after 
P. aeruginosa LPS challenge (Figure 3.5A). The phosphorylated state of Src at Tyr527 was not 
changed in macrophages after the stimulation by LPS from both E.coli and P. aeruginosa. These 
data indicated that Src signaling might be responsible for protein degradation of p120ctn in 
macrophages upon LPS stimulation. In order to test this hypothesis, PP2, an inhibitor for Src-
family kinases, was used to pretreat the macrophages, followed by stimulation of E. coli LPS. As 
Figure 3.5C displayed, PP2 could partially inhibit the downregulation of p120ctn in response to 
LPS challenge.   
3.6 mRNA expression of proinflammatory cytokines in p120 catenin knockdown 
macrophages in response to LPS stimulation. 
To study the effects of p120ctn ablation on inflammation in macrophages, p120ctn 
knockdown THP-1 cell line was generated by transduction of cells with p120ctn-specific short 
hairpin RNA (shRNA). Random shRNA was used as control. p120ctn knockdown in THP-1 cell 
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line was verified via RT-PCR and Western blot. PCR and Western blot analyses revealed a 
dramatic reduction of both mRNA and protein levels of p120ctn compared with shRNA control 
cells (Figure 3.6). As expected, p120ctn loss led to an increase in mRNA levels of proinflammatory 
cytokines in macrophages upon LPS treatment, especially within 8 hours after LPS stimulation. 
The effects of p120ctn ablation on mRNA expressions of IL-1β, IL-8 and TNF-α were similar in 
macrophages stimulated by LPS from both E. coli and P. aeruginosa. p120ctn loss resulted in an 
upregulation of IL-6 expression in macrophages after E. coli LPS stimulation. However, P. 
aeruginosa LPS did not induce significant expression of IL-6 mRNA in THP-1 derived 
macrophages despite the loss of p120ctn (Figure 3.7). 
3.7 NF-κB signaling in p120 catenin knockdown macrophages in response to LPS challenge 
NF-κB is the master transcription factor for expression of proinflammatory cytokines in 
cells in response to LPS stimulation. Upon stimulation of LPS, IKKγ was phosphorylated and 
activated more rapidly in p120ctn knockdown macrophages (within 10 minutes), as compared with 
shRNA control cells. However, the loss of p120ctn did not increase the period of IKKγ activation. 
(Figure 3.8A). No significant differences were observed in IκBα degradation within 30 minutes 
after LPS stimulation in p120ctn knockdown macrophages as compared with control cells. (Figure 
3.8A). The nuclear translocation of NF-κB p65 was not significantly changed by the loss of 
p120ctn in macrophages upon LPS stimulation. The phosphorylation of nuclear NF-κB p65 at 
Ser536 in p120ctn knockdown macrophages seemed augmented within one hour after LPS 
treatment (Figure 3.8, B and C).   
3.8 Loss of p120 catenin decreases LPS-induced autophagy in THP-1 derived macrophages  
Western blot analysis of p62 and LC3 was used to monitor the levels of autophagy. When 
autophagy is induced, LC3-I is conjugated to PE to form LC3-II, which is recruited to the 
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phagophore. p62 delivers ubiquitinated proteins to the autophagosome and itself is degraded in the 
lysosome. LPS (E. coli) could induce autophagy in both p120ctn knockdown and shRNA control 
macrophages (Figure 3.9A). The decreased basal level of p62 was observed in p120ctn knockdown 
macrophages as compared with shRNA control macrophages without LPS treatment. Upon 
stimulation of LPS, p62 was decreased in control macrophages for a short period (within 60 
minutes), followed by upregulated expression. In p120ctn knockdown macrophages, LPS induced 
time-dependent upregulation in p62 protein expression, and degradation of p62 was not significant 
(Figure 3.9B).   In order to compare the difference of the autophagy flux in p120ctn knockdown 
and shRNA control macrophages, an inhibitor bafilomycin A1 was used to block the autophagy. 
Bafilomycin A1 blocks maturation of autolysosome by inhibiting fusion of autophagosomes with 
lysosomes [270]. Macrophages was stimulated by LPS for 8 hours followed by treatment of 
bafilomycin A1 for another 1 hour. The decreased level of LC3-I and LC3-II was observed in 
p120ctn knockdown cells compared with shRNA control macrophages (Figure 3.9C). The change 
of p62 protein level was not observed in both p120ctn knockdown and control cells in response to 
inhibition of autophagy (Figure 3.9D). 
3.9 Autophagy-associated protein expression in p120 catenin knockdown macrophages in 
response to LPS challenge  
The process of LC3-I to LC3-II is regulated by several autophagy-associated proteins. The 
macrophages were stimulated by LPS for indicated time and Atg protein level was tested by 
Western blot. The protein level of Atg3, Atg7 and Atg16L1was not changed in both p120ctn 
knockdown and control macrophages upon LPS challenge (Figure 3.10, A, B and C). Conjugated 
Atg12-Atg5 was gradually downregulated 8 hours after LPS stimulation (Figure 3.10 D). 
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Table 2.1. Primers used to identify p120ctn isoforms [268]  
Primers Sequence  5’→3’ Tm (℃) Fragment size (bp) 
Total p120ctn: 
CAGCATGAGCGAGGAAGTTT 
ATGGCGTGGCTTACAGTCTT 
55 540 
Isoforms 1, 2, 3: 
TGCCCTGCTGGATTTGTCTT 
CGAGTGGTCCCATCATCTG 
56 
705 (1),  477 (2),  
225/297/319/369 (3) 
Isoforms A, B: 
AAACCTGATCGGGAAGAAAT 
ACTGGCAAAAAGAACTAATC 
52 470 (A),  557 (B) 
Isoform C: 
TTGCCTTCTTCGGAACTTAT 
CACTGTATCGTTTGCTGGAT 
52 193 
GAPDH 
ATCTTCCAGGAGCGAGATC 
ACCACTGACACGTTGGCAGT 
58 503 
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Table 2.2. Primers used to examine cytokine expression 
Primers Sequence  5’→3’ Tm (℃) Fragment size (bp) 
IL-1β 
ACGCTCCGGGACTCACAGCAA   
TTGAGGCCCAAGGCCACAGGTATT   
58 164 
IL-8 
CGTGGCTCTCTTGGCAGCCTTC 
TTTCTGTGTTGGCGCAGTGTGGTC 
58 179 
IL-6 
CAATGAGGAGACTTGCCTGGTG 
GGTTGGGTCAGGGGTGGTTA 
52 193 
TNF-α  
GCTGCACTTTGGAGTGATCG 
GCTTGAGGGTTTGCTACAACA 
52 144 
GAPDH 
ATCTTCCAGGAGCGAGATC 
ACCACTGACACGTTGGCAGT 
58 503 
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Table 3.1. The p120 catenin isoforms expressed in various cell lines 
Cell line Isoforms Length (aa) MW (kD) 
THP-1 1A, 3A 933, 832 104, 93 
THP-1 derived macrophage 1A, 3A 933, 832 104, 93 
A549 1A, 3A 933, 832 104, 93 
Calu3 3A, 3AB 832, 861 93, 96 
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Figure 1.1. Candherin/catenin complex. The extracellular domain of cadherin interacts in a 
homophilic fashion to form adherens junction between adjacent cells. Cadherin function is 
modulated by a group of catenins. β-Catenin binds to the catenin-binding domain of cadherin and 
functionally links cadherin with the actin cytoskeleton through α-catenin, while p120ctn is 
responsible for stabilizing cadherin-catenin complexes at the cell surface by interacting with the 
juxtamembrane domain of cadherin.  
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Figure 1.2. Schematic representation of human p120 catenin isoforms. Multiple isoforms of 
p120ctn result from the use of alternative start codons (M) and alternative splicing exons A (880-
900, 21aa), B (937-965, 29aa) and C (626-631, 6aa). Sizes are indicated in amino acid residues 
(aa). Arm 6: 583-624aa. M: Methionine start codons. CCD: coiled coil domain (10-46, 37aa). RD: 
regulatory domain. This figure was sketched based on the information from Uniprot (UniProtKB - 
O60716 CTND1_HUMAN).  
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Figure 1.3. Toll-like receptor 4 (TLR4) signaling. TLR4 initiates intracellular signaling by at 
least two major pathways: (1) MyD88-dependent/TIRAP–MyD88 pathway.TLR4 signals through 
the key adaptors MyD88/TIRAP to recruit downstream kinase IRAK. Activated IRAK then 
associates with TRAF6, resulting in the activation of two signaling pathways. One pathway leads 
to activation of transcription factor AP-1 through MAPK activation cascade. Another pathway 
activates IKK complex, leading to nuclear translocation of transcription factor NF-κB. MyD88-
depedent pathway regulates the production of inflammatory cytokines, such as IL-1 and IL-12. (2) 
MyD88-independent TRIF–TRAM pathway, which activates IRF3 transcription factor, leading to 
the subsequent expression of the type I IFN.  
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Figure 1.4. The process of macroautophagy in mammalian cells. A portion of cytoplasm is 
enclosed by an isolation membrane (phagophore) to form an autophagosome. The outer membrane 
of the autophagosome subsequently fuses with the lysosome, and the internal material is degraded. 
The nomenclature for various autophagic structures and stages of autophagy are indicated. 
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Figure 1.5. Two protein conjugation systems required for autophagosome formation. Atg12 
is covalently conjugated to Atg5 in a process assisted by the enzymes Atg7 and Atg10. Atg12–
Atg5 conjugates form a complex with Atg16L1 (Atg12-Atg5-Atg16L1 complex). Pro-LC3 is first 
cleaved by Atg4 at the carboxyl terminus to expose a glycine residue. Then LC3-I is ligated to the 
lipid phosphatidylethanolamine (PE) to form LC3-II in the process assisted by Atg7, Atg3 and 
Atg12-Atg5-Atg16L1 complex. 
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Figure 3.1. THP-1 cells were induced to differentiate into macrophages (THP-1 derived 
macrophages). (A). The human monocytic cell line THP-1 cells were differentiated into THP-1 
derived macrophages by culturing with PMA (10 ng/ml) for 3 days. The morphology of monocytic 
cell THP-1 and macrophages was analysed by microscope. (B). THP-1 derived macrophages were 
stimulated with LPS from Pseudomonus aeruginosa 10 (1 μg/ml) for 12 hours and 24 hours. The 
mRNA expression of pro-inflammatory cytokines including IL-1α, IL-8 and TNF-α was tested via 
reverse transcription PCR. 
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Figure 3.2. p120 Catenin isoform expression in THP-1 cells and THP-1 derived macrophages. 
mRNA expression of p120ctn isoforms 1, 2 and 3 (A), isoforms A and B (B), as well as isoforms 
C (C) was analyzed by RT-PCR in THP-1 cells, THP-1 derived macrophages (TDM), and lung 
cancer cell lines including A549 and Calu-3. The total mRNA expression (D) and protein 
expression (E) of p120ctn were tested in those four cell lines. The isoform codes and their fragment 
sizes are depicted.  
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Figure 3.3. p120 Catenin expression in THP-1 derived macrophages in response to LPS 
stimulation. (A). THP-1 derived macrophages were stimulated with 1 μg/ml of LPS from E. coli 
and P. aeruginosa for indicated time intervals. Total expression of p120ctn was analyzed via 
Western blot. (B). mRNA expression of p120ctn was tested via RT-PCR in macrophages after 
treatment with 1 μg/ml of LPS (E. coli). (C). p120ctn degradation was inhibited by autophagy 
inhibitor bafilomycin A1 in macrophages in response to the stimulation of 1 μg/ml of LPS from 
E. coli. (D). Subcellular distribution of p120ctn was analyzed in THP-1 derived macrophages after 
stimulation with 1 μg/ml of LPS from P. aeruginosa.  
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Fig 3.4. Comparison of TLR4 signaling in THP-1 derived macrophages in response to the 
stimulation of LPS from E. coli and P. aeruginosa.  Western blot analysis of MAPK and Akt 
signaling in macrophages upon stimulation of LPS (1 μg/ml) from P. aeruginosa (A) and E. coli 
(B). NF-κB signaling was compared in macrophages after stimulation with P. aeruginosa LPS (C) 
and E. coli LPS (D)   
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Fig 3.5. Signaling of tyrosine kinase Src associated with downregulation of p120 catenin in 
THP-1 derived macrophages after LPS (E. coli) stimulation. Src activation was analyzed in 
macrophages after treatment with P. aeruginosa LPS (A) and E. coli LPS (B). (C). Macrophages 
were pretreated with Src inhibitor PP2 (10 μM) for 30 minutes, followed by stimulation of 1 μg/ml 
of LPS (E. coli) for 2 hours. p120ctn expression level was examined by Western blot.  
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Figure 3.6. Verification of p120 catenin knockdown in THP-1 derived macrophages. shRNA 
lentivirus targeting p120ctn was used to knock down the expression of p120ctn in THP-1 derived 
macrophages. The mRNA level (A) and protein expression (B) of p120ctn were tested after shRNA 
transfection.   
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Figure 3.7. mRNA expression of proinflammatory cytokines in p120 catenin knockdown 
macrophages in response to LPS stimulation. The mRNA expression of proinflammatory 
cytokines, including IL-1β, IL-8, TNF-α and IL-6, was analyzed via RT-PCR in p120ctn-
knockdown and shRNA control macrophages upon stimulation of LPS (100 ng/ml) from P. 
aeruginosa (A) and E. coli (B).   
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Figure 3.8. NF-κB signaling in p120 catenin knockdown macrophages in response to LPS (P. 
aeruginosa) stimulation. (A). The phosphorylation of IKKβ and degradation of IκBα were 
detected via Western blot in p120ctn-knockdown and shRNA control macrophages upon 
stimulation of LPS. After stimulation of LPS in p120ctn-knockdown and shRNA control 
macrophages, the translocation and phosphorylation NF-κB p65 at Ser536 (B) and (C) was 
analyzed by western blot. GAPDH and Lamin B1 were used as cytoplasmic and nulcear internal 
controls respectively. 
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Figure 3.9. LPS-induced autophagy in p120 catenin knockdown THP-1 derived 
macrophages. p120ctn-knockdown and shRNA control macrophages were treated with 100 ng/ml 
of LPS (E. coli) for indicated time. Autophagy was tested by Western blot analysis of LC3 (A) and 
p62 (B). The macrophages were stimulated with 100 ng/ml of LPS (E. coli) for 8 hours, followed 
by treatment with autophagy inhibitor bafilomycin A1 (1μM) (DMSO as vehicle control) for 1 
hour. LC3 (C) and p62 (D) was then analyzed by Western blot. 
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Figure 3.10 Expression of autophagy-associated proteins Atgs in p120 catenin knockdown 
THP-1 derived macrophages after LPS treatment. p120ctn-knockdown and shRNA control 
macrophages were treated with 100 ng/ml of LPS (E. coli) for indicated time. Autophagy-
associated proteins including Atg3 (A), Atg7 (B), Atg16L1 (C) and conjugated Atg12-Atg5 (D) 
were compared between p120ctn-knockdown macrophages and shRNA control macrophages by 
Western blot. 
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CHAPTER 4 DISCUSSION, CONCLUSIONS AND FUTURE DIRECTIONS 
4.1 Discussion 
The incidence of severe sepsis is estimated to be 300 cases per 100,000 population in the 
United States [271]. European Prevalence of Infection in Intensive Care (EPIC II) study reported 
that the predominant organisms were Staphylococcus aureus (20.5%), Pseudomonas species 
(19.9%), Enterobacteriaceae (mainly E. coli, 16.0%), and fungi (19%), with Gram-negative 
organisms being still prevalent [272]. Sepsis associated with Gram-negative bacteria is a persistent 
problem all over the world. In spite of the development of new antibiotics, mortality from Gram-
negative bacteria sepsis remains very high [273]. The outer membrane component of Gram-
negative bacterial, LPS, is recognized as the most potent microbial mediator implicated in the 
pathogenesis of sepsis and septic shock [274]. The levels of circulating LPS can predict 
development of multi-organ failure, including acute respiratory distress syndrome [275]. LPS as a 
component of Gram-negative bacterial membrane has been used as a model representing Gram-
negative bacteria-induced inflammation [276, 277].  In order to study the effects of p120ctn on 
inflammatory reactions in macrophages, LPS was used to stimulate macrophages in my studies.  
Cell model for studying human p120 catenin functions in macrophages 
There are several cell models for studying human macrophage, such as THP-1, U937, and 
HL-60. THP-1 cell line was established from the peripheral blood of a 1-year old male patient with 
acute monocytic leukemia [278]. This cell line has been widely used to study immune responses 
in the monocyte state and in the macrophage-like state [279, 280]. THP-1 cells can be 
differentiated into a macrophage-like phenotype by using either PMA, or 1α, 25-dihydroxyvitamin 
D3 (Vit D3) [279]. Vit D3-induced differentiation of THP-1 cells resulted in macrophages less 
similar to human monocyte derived macrophages in terms of phagocytic activity and production 
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of IL-1β and TNF-α, as compared with THP-1 derived macrophages generated by using PMA 
[279]. Compared with heterogeneous PBMC monocytes from individual donors, the homogeneous 
genetic background of THP-1 could minimize the degree of phenotype variability, which facilitates 
reproducibility of studies. Moreover, PBMC monocytes require cytokines, such as IL-1β or TNF-
α, granulocyte-monocyte-colony stimulating factor or IFN-γ to function as survival factors to 
prevent apoptosis, whereas, THP-1 cells can be easily cultured, as well as be stocked in liquid 
nitrogen [281, 282].  Therefore, THP-1 cell line is the optimal monocyte model. PMA is the most 
effective and universally used differentiation agent to acquire THP-1 derived macrophages with 
similarities to human monocyte derived macrophages [281]. In my study, 10 ng/ml of PMA was 
used to induce THP-1 cells to differentiate into macrophage-like cells. After 3-day culturing with 
PMA, THP-1 monocytes acquired typical morphological features of macrophage: adhesive to 
culturing plate and flatten into irregular and elongated cells with short protrusions. The production 
of proinflammatory chemokines and cytokines was also used to identify one of the typical 
functions of macrophages in response to LPS stimulation. As shown in Figure 3.1B, PMA-induced 
THP-1 derived macrophages could respond to LPS challenge in terms of the proinflammatory 
cytokine expression.  
Isoforms of p120 catenin in THP-1 derived macrophages 
Divergent expression patterns of p120ctn isoforms have been observed in a tissue- and cell-
type-specific manner [22, 283, 284]. The cell type-specific expression of p120ctn isoforms was 
evident. The expression of p120ctn isoforms varies in abundance among different cell types [18].  
It has been reported that the mesenchymal and motile cells, such as macrophages and fibroblasts, 
express p120ctn long isoforms, whereas the epithelial or endothelial cells predominantly express 
short isoforms [22]. In my study, the RT-PCR and Western blot analysis showed that both THP-1 
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monocytes and THP-1 derived macrophages express p120ctn isoform 1A and 3A. Compared with 
THP-1 monocytes, PMA-induced macrophages express higher level of p120ctn isoform 1A and 
3A . The increased expression of p120ctn might be a marker for monocyte differentiation. But this 
would require using multiple monocyte/macrophage cell models to figure out the PMA effect on 
the expression of p120ctn.  My study demonstrated that monocytes or macrophages could express 
more than one isoforms, possibly both long isoform (isoform 1A) and short isoform (isoform 3A). 
Moreover, the preferential expression of either isoform was not observed in THP-1 cells and THP-
1 derived macrophages at least by the antibody used in this study. However, the subcellular 
distribution of p120ctn showed that the membrane would predominantly express the short isoform 
3A, and no significant difference of isoform expression was observed in cytoplasmic and nuclear 
part in macrophages (Figure 3.3D). It has been reported that in tumor cell lines, p120ctn isoform 
1A promoted the epithelial mesenchymal transition (EMT) and increased tumor cell invasiveness, 
while p120ctn isoform 3A showed the opposite effects on EMT and invasiveness [285]. But the 
functions of different p120ctn isoforms have not been very clear in macrophages. In addition, the 
profile of p120ctn isoform expression was not switched by LPS challenge (Figure 3.3A). p120ctn 
isoform 4 is rarely expressed as a protein [17], so this study didn’t examine the expression of 
isoform 4 in macrophages.  
LPS-induced degradation of p120 catenin in THP-1 derived macrophages 
Previous study revealed that LPS challenge could reduce p120ctn protein expression in 
mouse lungs and pulmonary endothelial cells [263]. The p120ctn protein level was correlated 
inversely with severity of lung inflammation. Knockdown of p120ctn also increased the neutrophil 
recruitment, production of cytokines TNF-α and IL-6, and pulmonary transvascular permeability 
in response to LPS [263].  p120ctn expression was also observed to be significantly reduced after 
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LPS stimulation in human bronchial epithelial cell line [286]. My research revealed that P. 
aeruginosa LPS could not induce p120ctn downregulation or redistribution in macrophages, 
whereas E. coli LPS reduced the p120ctn expression in macrophages within 4 hours after LPS 
treatment. Moreover, the mRNA expression level of p120ctn was not decreased by E. coli LPS 
stimulation, which indicated that the decreased protein level was not attributed to reduced mRNA 
level of p120ctn. Next, the pathways responsible for p120ctn degradation were analyzed by using 
inhibitors targeting proteasome and autophagy respectively. As shown in Figure 3.3C, autophagy 
inhibitor bafilomycin A1, but not proteasome inhibitor MG132, suppressed the LPS-induced 
degradation of p120ctn, which suggests that autophagy pathway might contribute to the 
degradation of p120ctn in macrophage upon E. coli LPS challenge. One of the selective 
degradation by autophagy is mediated through autophagy adaptor protein p62 which could 
recognize K63-ubiquitinated proteins. Behrends et al reported a proteomic analysis of the 
autophagy interaction network in human cells under basal autophagy, which revealed a network 
of 751 interactions among 409 candidate interacting proteins [287]. In this research, p120ctn-p62 
interaction in HEK293 cells was identified via affinity-capture mass spectrometry by using p62 as 
a bait [287]. Selective autophagy can also be mediated by the interaction between LIR motif of the 
target and the autophagy protein LC3, which targets selected cargo to a nascent autophagosome. 
The core LIR motif is (W/F/Y)XX(L/I/V), where X is any other residue.  This sequence is 
surrounded by at least one acidic residue [179, 288]. Examination of p120ctn amino-acid sequence 
(reference sequence: NP_001078927.1) revealed a potential LIR motif “WAPL” at positions 336-
339aa upstream of the N-terminal Arm domain. Also, an aspartic acid residue is located upstream 
of this motif (-4) together with two tyrosine residues and one serine residue nearby which might 
be associated with the mechanism of regulating the protein interactions. Another Arm domain 
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family membrane β-catenin was reported to contain a potential LIR motif (WPLI) at positions 
504–507 within the Arm domains (Arm 9) [289] . During nutrient deprivation β-catenin was 
selectively degraded via the formation of a β-catenin–LC3 complex mediated by the LIR motif. 
The interaction between LC3 and β-catenin was required for non-proteasomal degradation of β-
catenin [289].  However, the further co-immunoprecipitation and mutation assays are required to 
confirm the pathway responsible for p120ctn degradation via selective autophagy in macrophage 
upon LPS stimulation. Some other studies reported that p120ctn was phosphorylated by casein 
kinase (CK)-1α and glycogen synthase kinase (GSK) 3β, and then degraded through the ubiquitin-
proteasome pathway. The inhibition of proteasome pathway with MG132 could raise p120ctn 
levels in melanoma cells and 293T cells [72]. This indicated the pathways responsible for p120ctn 
degradation might be cell-context and signaling-pathway dependent. The activation of GSK3β or 
CK-1α signaling led to the proteasomal degradation of p120ctn [72], whereas, LPS-induced Src 
activation might be responsible for autophagy degradation of p120ctn.   
Comparing the signaling pathways revealed the similar activation patterns of the MAPK, 
Akt, and IKK-NF-κB signaling pathways activated by E. coli and P. aeruginosa LPS. p120ctn was 
originally identified as a Src substrate from v-Src-transformed chicken embryo fibroblasts [1]. 
Multiple sites of p120ctn tyrosine phosphorylation by Src were identified [74]. But the functional 
consequences of p120ctn tyrosine phosphorylation are not completely understood. Under some 
specific circumstances, in vitro and in vivo assays indicated that tyrosine-phosphorylation of 
p120ctn was correlated with an altered affinity of p120ctn for cadherins and the structural integrity 
of the adherens junctions [75, 81, 290, 291]. The macrophages do not form a static cell-cell 
adhesion, therefore, the p120ctn phosphorylation by Src and its degradation induced by LPS might 
be associated with the mobility of macrophages in inflammatory responses. 
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LPS is the major structural component present in the outer membrane of Gram-negative 
bacteria that can trigger innate immune responses through TLR4. LPS is composed of three distinct 
units: the hydrophobic phospholipid known as lipid A, a core oligosaccharide, and an outer 
polysaccharide called O antigen [292]. Studies employing synthesized lipid A have demonstrated 
that lipid A is the major inflammation-inducing moiety of LPS [293, 294]. The diversity of 
structural motifs in the polysaccharide and the lipid A moieties accounts for the highly variable in 
vivo and in vitro responses to LPS [295].  However, the relationships between diverse structure of 
LPS and biological responses are complex, and studies have indicated that LPS isolated from 
particular bacterial strains can preferentially induce MyD88- or TRIF-dependent expression of 
cytokines [293]. My study revealed that LPS from two different bacterial strains (E. coli and P. 
aeruginosa) could induce diverse response in macrophages with respect to p120ctn expression. At 
present, the functional significance related to LPS-induced degradation of p120ctn in macrophages 
remains elusive. Further studies are required to define whether LPS-induced degradation of 
p120ctn is associated with distinct profile of cytokine expression and macrophage mobility.  
p120 Catenin suppresses LPS-induced NF-κB activation and proinflammatory 
cytokine expression 
Previous observations showed that p120-null epidermal cells exhibited increased NF-κB 
activation, resulting in elevated expression of proinflammatory cytokines and chemokines in vitro 
and in vivo [258, 259]. Wang et al revealed p120ctn expressed in endothelial cells could inhibit 
TLR4-mediated NF-κB signaling and lung inflammation [263]. These findings raise the possibility 
that p120ctn might have important roles in regulating immunity. In my research, p120ctn 
knockdown in macrophages also led to elevated activation of NF-κB signaling and mRNA 
expression of proinflammatory cytokines including IL-1β, IL-8, IL-6 and TNF-α. The loss of 
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p120ctn could not extend the time period of IKKβ activation, IκBα degradation or NF-κB nuclear 
translocation. Instead, p120ctn depletion resulted in more rapid activation of NF-κB signaling 
pathway.  
A number of kinases have been identified that phosphorylate NF-κB p65 at Ser536 in the 
transactivation domain, including IKKα, IKKβ, IKKε and NF-κB activating kinase/TBK1 [296, 
297]. The consequences of Ser536 phosphorylation of p65 would depend on the physiological 
context. For example, in 293T cells, TNF-α-induced phosphorylation at Ser536 of p65 displays 
enhanced transcriptional activity which is associated with increased acetylation of p65 [298]. 
Moreover, p65 Ser536 phosphorylation leads to the expression of a distinct set of target genes, 
which indicates phosphorylation of p65 might be associated with the selectivity of gene expression 
[299]. In my research, the phosphorylated p65 at Ser536 was increased transiently in nucleus in 
p120ctn knockdown macrophages after LPS stimulation. This might be associated with the 
upregulation of proinflammatory expression in p120ctn-depleted macrophages. Further studies are 
required to explain the functional association of p65 Ser536 phosphorylation with the cytokine 
expression. 
p120 Catenin is associate with LPS/TLR4-induced autophagy in THP-1 derived 
macrophages 
Pattern recognition receptor signaling that is induced following the recognition of PAMPs 
and DAMPs can activate autophagy [215, 216]. For example, activation of TLR4 leads to 
ubiquitination of the Beclin-1 by the E3 ligase TRAF6. Ubiquitinated Beclin-1 is released from its 
inhibitor Bcl-2 and becomes active [154]. TRAF6 also activates ULK1 through ubiquitination 
[300]. TLR activation also promotes the interaction of MyD88 and TRIF with Beclin-1, which 
reduces the binding of Beclin-1 to Bcl-2 [301]. 
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Autophagy also facilitates TLR signaling by transferring cytosolic pathogen components 
to their cognate endosomal TLRs [227]. Autophagosome plays an important role in delivery of 
antigen to antigen-loading compartments for MHC II presentation [302]. 
Autophagy is a dynamic process through which eukaryotic cells degrade long-lived or 
misfolded proteins, and impaired or superfluous cytoplasmic organelles, as well as recycle 
autophagy-derived nutrients [303]. Autophagy comprises sequential steps including the formation 
of autophagosomes, the fusion of autophagosomes with lysosomes and cargo degradation [121]. 
Autophagy is associated with a wide range of physiological and pathological processes, such as 
embryonic development, immunity, cancer, cardiovascular disease, muscular disease and 
neurodegenerative disease [130]. To date, the major methods used to monitor autophagic 
activation are the Western blot analysis of LC3 processing and detection of autophagosome 
formation by fluorescence or electron microscopy [304]. However, autophagy is a highly dynamic 
process with multiple steps. The increased LC3-II levels observed via Western blot or the 
accumulation of autophagosomes detected by microscope could indicate either the activation of 
autophagy or a blockage of downstream steps in autophagy, such as inefficient fusion or decreased 
lysosomal degradation. Therefore, the mere detection of the presence of LC3 processing is 
insufficient for an overall evaluation of the entire autophagic system. Evaluation of the rate of 
autophagic degradation, defined as autophagic flux, seems more accurate to assess the whole 
dynamic process of autophagy [305, 306]. In this research, LPS-induced autophagy was compared 
between p120ctn knockdown THP-1 derived macrophages and shRNA control macrophages. The 
conversion of LC3-I to LC3-II, an indicator of autophagy activation, was assessed by immunoblot 
analysis with LC3 antibody. As shown in Figure 3.9A, LC3-II abundance was increased by LPS 
challenge in a time-dependent manner in both p120ctn knockdown macrophages and shRNA 
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control macrophages. Generally, without inhibition of autophagy process, LC3-II level was 
observed to be gradually increased 8 hours after LPS treatment, and reached the highest level 
around 16 hours of LPS treatment. Since the autophagic process is highly dynamic and 
autophagosomes turn over rapidly, the absolute level of LC3-II at specific time point after LPS 
stimulation might not represent the real rate of autophagy flux unless lysosomal degradation is 
blocked. By using bafilomycin A1 to block the fusion of autophagosome with lysosome, an 
increase of LC3-II level was observed in both p120ctn knockdown and control macrophages after 
LPS challenge (Figure 3.9C). But, the elevated level of LC3-II was significantly lower in p120ctn 
knockdown macrophages as compared with control cells. Without LPS stimulation, the inhibition 
of autophagy with bafilomycin A1 could also increase the abundance of LC3-II similarly in both 
macrophages, suggesting that basal level of autophagy might not be affected by the loss of p120ctn 
in macrophages. 
p62 has an N-terminal PB1 domain followed by a zinc finger domain, and a C-terminal 
UBA domain [307]. p62 could bind to polyubiquitin via its UBA domain and thus recruit 
ubiquitinated protein aggregates [308, 309]. The N-terminal PB1 domain is used for the 
polymerization of p62 and for binding to other proteins containing PB1 domains [310]. p62, 
together with the bound cargoes, is degraded by autophagy, so p62 may also be used as an 
autophagic marker [173]. My data demonstrated that LPS could induce a transient downregulation 
of p62 followed by upregulation and maintaining at a high level in shRNA control macrophages 
(Figure 3.9B). The LPS-induced decrease of p62 was not observed in p120ctn knockdown 
macrophages, whereas the gradual increase was evident during the course of LPS challenge. 
TRAF6 is the essential mediator for activation of NF-κB pathway induced by LPS, 
proinflammatory cytokines and growth factors [311]. p62 also functions to facilitate K63-
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polyubiquitination of TRAF6 and thereby mediates the activation of the NF-κB pathway [311]. As 
shown in Figure 3.9 B and D, p62 level was increased by LPS and could not be further elevated 
by bafilomycin A1. Hence, the increase of p62 might result from LPS-induced activation of NF-
κB signaling in THP-1 derived macrophages. This is consistent with another study which 
demonstrated that LPS treatment led to induction of p62 mRNA and protein in mouse bone 
marrow-derived macrophages [312]. As an adaptor protein, p62 is involved in multiple biologic 
processes, such as NF-κB activation and protein degradation via autophagy. The predominant 
functions of p62 might be cell-context dependent. p62 may display distinctive functions in 
response to different stimuli. In this THP-1 derived macrophage model, instead of autophagic 
degradation, p62 might be mainly involved in the activation of NF-κB signaling pathway via 
interaction with TRAF6.  As the Figure 3.9B showed, the basal level of p62 was lower in p120ctn 
knockdown macrophages as compared with control cells. The mechanisms responsible for p62 
downregulation in p120ctn-depleted cells remains unclear, and further study is warranted.  
Covalently conjugated Atg12-Atg5 forms a multimeric complex with Atg16L1, which 
functions as ubiquitin-protein ligase E3-like enzyme essential for LC3-PE conjugation reaction 
and therefore for autophagosome formation [313, 314]. Without any stimulation, Atg12 has been 
constitutively conjugated to Atg5 [315]. The level of conjugated Atg12-Atg5 was downregulated 
8 hours after LPS treatment in p120ctn knockdown macrophages. This might be one of the reasons 
for the decreased activity of LPS-induced autophagy in p120ctn knockdown macrophages. The 
mechanism by which the loss of p120ctn affects the expression of conjugated Atg12-Atg5 needs 
further studies. 
4.2 Conclusions 
In conclusion, p120ctn has conserved anti-inflammatory functions across different cell 
types including epithelial cells, endothelial cells and macrophages. NF-κB signaling pathway 
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might be the common regulatory target. The downregulation of p120 catenin in the macrophages 
in response to E. coli LPS stimulation might be regulated by Src signaling and autophagy. The 
depletion of p120ctn results in the decreased activity of LPS-induced autophagy in THP-1derived 
macrophages. The loss of p120ctn leads to downregulation of conjugated Atg12-Atg5 in 
macrophages upon LPS stimulation. The abnormal autophagy might contribute to the over-
activation of LPS-induced inflammation in p120ctn knockdown macrophages. 
4.3 Future directions 
The LPS-induced downregulation of p120ctn was revealed in this study. Future research is 
required in order to explore how p120ctn is degraded via autophagy and whether the 
downregulation of p120ctn is associated with the distinct patterns of proinflammatory cytokine 
expression. The defective LPS-induced autophagy was displayed in p120ctn-depleted 
macrophages. Further studies will be performed to determine how p120ctn influences Atg12-Atg5 
conjugation.  
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ABSTRACT 
P120 CATENIN REGULATES INFLAMMATION IN MACROPHAGE 
by 
XIAOQING GUAN 
May 2017 
Advisor: Dr. Chunying Li  
Major: Biochemistry  
Degree: Doctor of Philosophy 
Objective: p120 catenin (p120ctn) has been reported to play a critical role in maintenance 
of the stability of adherens junctions. It also has potential anti-inflammatory effects in epithelial 
and endothelial cells. This research was designed to evaluate the effects of p120ctn on 
inflammatory responses in human macrophages upon LPS stimulation, as well as the possible 
mechanism by which p120ctn regulates LPS-induced proinflammatory response in macrophages.  
Methods:   THP-1 cells were induced to differentiate into macrophages by PMA. The isoforms of 
p120ctn were identified via RT-PCR and Western blot. The expression of p120ctn was examined 
by Western blot in THP-1 derived macrophages after LPS challenge. p120ctn was knocked down 
in THP-1 cells by using shRNA lentivirus particles. mRNA level of proinflammatory cytokines 
were evaluated by RT-PCR. The autophagy pathway was analyzed by Western blot in 
macrophages after LPS stimulation with or without Bafilomycin A1 treatment. Results: THP-1 
derived macrophages expressed p120ctn isoform 1A and 3A. E. coli LPS could downregulate 
p120ctn expression in macrophage via autophagy pathway, which was suppressed by Src signaling 
inhibitor PP2. mRNA levels of proinflammatory cytokines including IL-1β, IL-8, IL-6 and TNF-
α were elevated in p120ctn-delpeted macrophages in response to LPS stimulation, as compared 
with control cells. The activation of NF-κB signaling pathway was more rapid in p120ctn 
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knockdown macrophages in response to LPS treatment. Decreased autophagy and downregulation 
of conjugated Atg12-Atg5 were observed in p120ctn knockdown macrophages after LPS 
challenge. Conclusions:  The downregulation of p120ctn in the macrophages in response to E. coli 
LPS stimulation is regulated by Src signaling and autophagy. p120ctn has anti-inflammatory 
functions in macrophages. NF-κB signaling pathway might be the regulatory target. The loss of 
p120ctn results in the decreased activity of LPS-induced autophagy and downregulation of 
conjugated Atg12-Atg5 in macrophages upon LPS stimulation, which might contribute to the over-
activation of LPS-induced inflammation in p120ctn knockdown macrophages.  
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